Short-term and long-term safety and efficacy of tenofovir alafenamide, tenofovir disoproxil fumarate and entecavir treatment of acute-on-chronic liver failure associated with hepatitis B

Short-term and long-term safety and efficacy of tenofovir alafenamide, tenofovir disoproxil fumarate and entecavir treatment of acute-on-chronic liver failure associated with hepatitis B

Abstract Background & Aims There is limited evidence on the efficacy and safety of nucleos(t) ide analogues (NAs) in the treatment of HBV-ACLF. Our objective was to evaluate the outcomes among TAF, TDF and ETV, three first-line antivirals against chronic hepatitis B, in patients with HBV-ACLF. M...

Full description

Bibliographic Details
Main Authors: Juan Li, Chunhua Hu, Yi Chen, Rou Zhang, Shan Fu, Mimi Zhou, Zhijie Gao, Mengjun Fu, Taotao Yan, Yuan Yang, Jianzhou Li, Jinfeng Liu, Tianyan Chen, Yingren Zhao, Yingli He
Format: Article
Language:English
Published: BMC 2021-06-01
Series:BMC Infectious Diseases
Subjects:
Tenofovir alafenamide
Tenofovir disoproxil fumarate
Entecavir
Hepatitis B virus
Acute-on-chronic liver failure
Online Access:https://doi.org/10.1186/s12879-021-06237-x

Internet

https://doi.org/10.1186/s12879-021-06237-x

Similar Items